About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
COMPANY NEWS
Company
News
Bharat Parenterals Ltd.
Change Company
BSE Code
541096
ISIN Demat
INE365Y01019
Book Value
581.56
NSE Code
NA
Dividend Yield %
0.10
Market Cap
6915.05
P/E
40.86
EPS
24.56
Face Value
10
1 Week
1 Month
3 Months
6 Months
1 Year
13-Jan-2026
Bharat Parenterals informs about newspaper public...
09-Jan-2026
Bharat Parenterals informs about confirmation ce...
09-Dec-2025
Bharat Parenterals informs about report on trans...
04-Dec-2025
Bharat Parenterals informs about newspaper public...
28-Nov-2025
FAMHP concludes EU GMP inspection at facility of ...
27-Nov-2025
Bharat Parenterals informs about analyst meet
04-Sep-2025
Bharat Parenterals informs about AGM
31-Jul-2025
Bharat Parenterals touches roof as its arm receiv...
30-Jul-2025
Bharat Parenterals’ arm receives EIR from USFDA f...
22-Jul-2025
Bharat Parenterals informs about board meeting
05-May-2025
Bharat Parenterals’ arm clears USFDA inspection a...
05-May-2025
Bharat Parenterals touches the roof on the BSE
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.